___

• Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-40.
• Bouchard C. BMI, fat mass, abdominal adipo-sity and visceral fat: where is the 'beef'? Int J Obes 2007; 31: 1552-3.
• Sellam J, Berenbaum F. Osteoarthritis and obe-sity. Rev Prat 2012; 62: 621-4.
• Altman RD, Hochberg MC, Moskowitz RW, et al. Recommendations for the medical manage-ment of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905-15.
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the mana-gement of hip osteoarthritis: report of a task for-ce of the EULAR Standing Committee for In-ternational Clinical Studies Including Therapeu-tics (ESCISIT). Ann Rheum Dis 2005; 64: 669-81.
• Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first natio-nal Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 1988; 128: 179-89.
• Collins JE, Donnell-Fink LA, Yang HY, et al. Effect of obesity on pain and functional reco-very following total knee arthroplasty. J Bone Joint Surg Am. 2017; 99: 1812-8.
• Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: An epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 2008; 9: 132.
• Kiadaliri AA, Lohmander LS, Moradi-Lakeh M, et al. High and rising burden of hip and knee os-teoarthritis in the Nordic region, 1990-2015. Acta Orthop 2018; 89: 177-83.
• Evans AL, Paggiosi MA, Eastell R, et al. Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res 2015; 30: 920-8.
• Reid IR, Ames RW, Evans MC, et al. Determi-nants of the rate of bone loss in normal postme-nopausal women. J Clin Endocrinol Metab 1994; 79: 950-4.
• Prieto-Alhambra D, Premaor MO, Fina Aviles F, et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res 2012; 27: 294-300.
• Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011; 124: 1043-50.
• Teichtahl AJ, Urquhart DM, Wang Y, et al. Physical inactivity is associated with narrower lumbar intervertebral discs, high fat content of paraspinal muscles and low back pain and disa-bility. Arthritis Res Ther 2015; 17: 114.
• Dario AB, Ferreira ML, Refshauge K, et al. Are obesity and body fat distribution associated with low back pain in women? A population-based study of 1128 Spanish twins. Eur Spine J 2016; 25: 1188-95.
• Ibrahimi-Kaçuri D, Murtezani A, Rrecaj S, et al. Low back pain and obesity. Med Arch 2015; 69: 114-6.
• Sharma A. The role of adipokines in interver-tebral disc degeneration. Med Sci (Basel) 2018; 6: E34.
• Hauner H. Secretory factors from human adipo-se tissue and their functional role. Proc Nutr Soc 2005; 64: 163-9.
• Van der Meer JW, Netea MG. A salty taste to autoimmunity. N Engl J Med 2013; 368: 2520-1.
• Lu B, Hiraki LT, Sparks JA, et al. Being overweight or obese and risk of developing rhe-umatoid arthritis among women: a prospective cohort study. Ann Rheum Dis 2014; 73: 1914-22.
• Stavropoulos-Kalinoglou A, Metsios GS, Kou-tedakis Y, et al. Redefining overweight and obe-sity in rheumatoid arthritis patients. Ann Rheum Dis 2007; 66: 1316-21.
• Katz PP, Yazdany J, Trupin L, et al. Sex diffe-rences in assessment of obesity in rheumatoid arthritis. Arthritis Care Res 2013; 65: 62-70.
• Jhun JY, Yoon BY, Park MK, et al. Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med 2012; 44: 424-31.
• Ajeganova S, Andersson ML, Hafström I; BARFOT Study Group. Association of obesity with worse disease severity in rheumatoid arth-ritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res 2013; 65: 78-87.
• Stavropoulos-Kalinoglou A, Metsios GS, Pano-ulas VF, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 2009; 28: 439-44.
• Jawaheer D, Olsen J, Lahiff M, et al. Gender, body mass index and rheumatoid arthritis disea-se activity: results from the QUEST-RA Study. Clin Exp Rheumatol 2010; 28: 454-61.
• Hassan MK, Joshi AV, Madhavan SS, Amonkar MM. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord 2003; 27: 1227-32.
• Klaasen R, Wijbrandts CA, Gerlag DM, et al. Body mass index and clinical response to inf-liximab in rheumatoid arthritis. Arthritis Rheum 2011; 63: 359-64.
• Gremese E, Ferraccioli G. The metabolic synd-rome: the crossroads between rheumatoid arthri-tis and cardiovascular risk. Autoimmun Rev 2011; 10: 582-9.
• Sandberg ME, Bengtsson C, Kallberg H, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis 2014; 73: 2029-33.
• Ottaviani S, Allanore Y, Tubach F, et al. Body mass index influences the response to inf-liximab in ankylosing spondylitis. Arthritis Res Ther 2012; 14: R115.
• Gremese E, Bernardi S, Bonazza S, et al. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis. Rheumatology 2014; 53: 875-81.
• Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observa-tional studies. Nutr Diabetes 2012; 2: 54.
• Bhole VM, Choi HK, Burns LC, et al. Differen-ces in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology 2012; 51: 552-6.
• Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012; 71: 1273-7.
• di Minno MN, Peluso R, Iervolino S, et al. Obe-sity and the prediction of minimal disease acti-vity: a prospective study in psoriatic arthritis. Arthritis Care Res 2013; 65: 141-7.
• Eder L, Thavaneswaran A, Chandran V, et al. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 2015; 74: 813-7.
• Oeser A, Chung CP, Asanuma Y, et al. Obesity is an independent contributor to functional ca-pacity and inflammation in systemic lupus eryt-hematosus. Arthritis Rheum 2005; 52: 3651-9.
• Lozovoy MA, Simao AN, Hohmann MS, et al. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic synd-rome. Lupus 2011; 20: 1356-64.
• Chaiamnuay S, Bertoli AM, Roseman JM, et al. African-American and Hispanic ethnicities, re-nal involvement and obesity predispose to hy-pertension in systemic lupus erythematosus: re-sults from LUMINA, a multiethnic cohort (LUMINAXLV). Ann Rheum Dis 2007; 66: 618-22.
• Marighela TF, Genaro Pde S, Pinheiro MM, et al. Risk factors for body composition abnorma-lities in systemic sclerosis. Clin Rheumatol 2013; 32: 1037-44.
• Assassi S, Del Junco D, Sutter K, et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009; 61: 1403-11.
• Cornec D, Jamin C, Pers JO. Sjögren's syndro-me: where do we stand, and where shall we go? J Autoimmun 2014; 51: 109-14.
• Cotrim FP, Ribaric I, Mantovani E, et al. Dysli-pidemia in adult dermatomyositis and polymyo-sitisis not associated with anti-lipoprotein lipa-se. Austin J Musculoskelet Disord 2015; 2: 1026.
• Silva MG, Borba EF, Mello SB, et al. Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients. Clinics 2016; 71: 709-14.
• Beyl RN Jr, Hughes L, Morgan S. Update on importance of diet in gout. Am J Med 2016; 129: 1153-8.
• Lee J, Lee JY, Lee JH, et al. Visceral fat obesity is highly associated with primary gout in a me-tabolically obese but normal weighted popula-tion: a case control study. Arthritis Res Ther 2015; 17: 79.
• Zhen H, Gui F. The role of hyperuricemia on vascular endothelium dysfunction. Biomed Rep 2017; 7: 325-30.